Card image cap

Maggie Hassan's Public Statements on Issue: Drugs

Office:
1

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 4
Date Title
07/21/2022 Letter to Robert Califf, Commissioner of the Food and Drug Administration - Senators Hassan and Paul Press FDA to Increase Access to Life-Saving Naloxone
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
02/25/2022 Letter to Chuck Schumer, Senate Majority Leader, Patrick Leahy, Chair of the Senate Appropriations Committee, Chris Murphy, Chair of the Senate Subcommittee on Homeland Security - Peters Calls for Robust Funding to Support DHS Border Security and Drug Detection
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
10/05/2021 Letter to Hon. Anne Milgram, Administrator of the Drug Enforcement Agency - Senator Hassan Calls on the DEA to Combat Rise in Counterfeit, Dangerous Drugs
08/23/2021 Letter to Janet Woodcock, Acting Commissioner of Food and Drug Administration - Senators Hassan, Grassley, and Whitehouse Lead Call to FDA to Provide Answers on Potential Conflicts of Interest with Consulting Firm McKinsey in Relation to Opioid Crisis
07/26/2021 Letter to Hon. Robert Drain, New York District Judge - Senator Hassan, Colleagues Oppose Purdue Pharma's Request for Bonuses to Top Executives & Employees Amid Ongoing Opioid Epidemic
04/19/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Senator Markey Leads Colleagues in Urging Fda to Ban Menthol Cigarettes
04/16/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Feinstein, Markey, Colleagues Urge FDA to Ban Menthol Cigarettes
04/16/2021 Letter to Hon. Charles Rettig, Commissioner of Internal Revenue Service - Senators Hassan, Wyden Lead Push to Challenge Abusive Tax Deductions by Opioid Companies
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
11/10/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation
10/01/2020 Letter to the Hon. William Barr, Attorney General of the United States - Whitehouse, Hassan Call on Justice Department to Hold Purdue Accountable in Newly Revealed Settlement Negotiations
09/15/2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care
09/15/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice, and the Hon. Christopher Wray, Dir. of the Federal Bureau of Investigation - Feinstein, Hassan, Cornyn Request Details on Justice Department, FBI Efforts to Target Drug Trafficking on the Dark Web
07/17/2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Nancy Pelosi, Speaker of the House, and the Hon. Kevin McCarthy, House Minority Leader - In Response to a Rise in Drug Overdoses in NH, Congressional Delegation Calls for Additional Funding for Substance Use Disorder Services in Next COVID-19 Relief Package
05/19/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
04/17/2020 Letter to Alex Azar, Sec. of the Dep. of Health and Human Services, and Elinore McCance-Katz, Assistant Secretary for Mental Health and Substance Use - Feinstein, Markey, Warren, Shaheen Call on Trump Administration to Reduce Barriers to Lifesaving Opioid Treatment Medication During Coronavirus Pandemic
04/16/2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic
01/21/2020 Letter to the Hon. Donald J. Trump, President of the United States - NH Delegation Calls on Trump to Continue Opioid Response Grant Funding, Ensure Set-Aside for Hardest-Hit States
12/17/2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO
12/05/2019 Letter to the Hon. William Barr, Attorney General of the U.S. Department of Justice - New Hampshire and Massachusetts Senators Request Update on Justice Department's Use of Medication-Assisted Treatment for Incarcerated Individuals
Page 1 of 4
arrow_upward